Yarrow Bioscience Inc ( YARW) - Key Metrics
YARW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.11 | -$3.50 | -$2.32 | -$2.32 |
| 2026Q1 | $5.03 | -$209.56 | -$238.56 | -$238.56 |
| 2025Q4 | $7.60 | -$282.75 | -$220.03 | -$220.03 |
| 2025Q3 | $9.88 | -$425.78 | -$415.02 | -$415.02 |
| 2025Q2 | $4.03 | -$336.47 | -$631.61 | -$631.61 |
YARW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.32 |
| 2026Q1 | 0% | -0.04 |
| 2025Q4 | 0% | -0.03 |
| 2025Q3 | 0% | -0.01 |
| 2025Q2 | 0% | -0.06 |
YARW
Price: $36.42
52 week price:
Forward Dividend Yield: 0.04%
Dividend Per Share: 0.02 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 110.8 million
Average Dividend Frequency: 2
Years Paying Dividends: 1